<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Verdone BM</submitter><funding>NIA NIH HHS</funding><funding>The Professor Fredric Rieders, PhD scholarship</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>Muscular Dystrophy Association</funding><pagination>5644</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8979946</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Translation of the hexanucleotide G4C2 expansion associated with C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) produces five different dipeptide repeat protein (DPR) species that can confer toxicity. There is yet much to learn about the contribution of a single DPR to disease pathogenesis. We show here that a short repeat length is sufficient for the DPR poly-GR to confer neurotoxicity in vitro, a phenomenon previously unobserved. This toxicity is also reported in vivo in our novel knock-in mouse model characterized by widespread central nervous system (CNS) expression of the short-length poly-GR. We observe sex-specific chronic ALS/FTD-like phenotypes in these mice, including mild motor neuron loss, but no TDP-43 mis-localization, as well as motor and cognitive impairments. We suggest that this model can serve as the foundation for phenotypic exacerbation through second-hit forms of stress.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS/FTD-like phenotypes.</pubmed_title><pmcid>PMC8979946</pmcid><funding_grant_id>RF1-NS114128</funding_grant_id><funding_grant_id>628389</funding_grant_id><funding_grant_id>RF1 AG057882</funding_grant_id><funding_grant_id>R01-NS109150</funding_grant_id><funding_grant_id>RF1 NS114128</funding_grant_id><funding_grant_id>R21-NS090912</funding_grant_id><pubmed_authors>Verdone BM</pubmed_authors><pubmed_authors>Cicardi ME</pubmed_authors><pubmed_authors>Wen X</pubmed_authors><pubmed_authors>Sriramoji S</pubmed_authors><pubmed_authors>Krishnamurthy K</pubmed_authors><pubmed_authors>Trotti D</pubmed_authors><pubmed_authors>Markandaiah SS</pubmed_authors><pubmed_authors>Haeusler AR</pubmed_authors><pubmed_authors>Jensen BK</pubmed_authors><pubmed_authors>Pasinelli P</pubmed_authors><pubmed_authors>Russell K</pubmed_authors></additional><is_claimable>false</is_claimable><name>A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS/FTD-like phenotypes.</name><description>Translation of the hexanucleotide G4C2 expansion associated with C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) produces five different dipeptide repeat protein (DPR) species that can confer toxicity. There is yet much to learn about the contribution of a single DPR to disease pathogenesis. We show here that a short repeat length is sufficient for the DPR poly-GR to confer neurotoxicity in vitro, a phenomenon previously unobserved. This toxicity is also reported in vivo in our novel knock-in mouse model characterized by widespread central nervous system (CNS) expression of the short-length poly-GR. We observe sex-specific chronic ALS/FTD-like phenotypes in these mice, including mild motor neuron loss, but no TDP-43 mis-localization, as well as motor and cognitive impairments. We suggest that this model can serve as the foundation for phenotypic exacerbation through second-hit forms of stress.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-26T15:15:05.11Z</modification><creation>2025-04-06T14:51:05.508Z</creation></dates><accession>S-EPMC8979946</accession><cross_references><pubmed>35379876</pubmed><doi>10.1038/s41598-022-09593-z</doi></cross_references></HashMap>